Not to be diluted w/ water for inj. Discontinue immediately if allergic or anaphylactic type reactions occur; at 1st clinical signs of CV overload or increased BP, raised central venous pressure & pulmonary oedema. Hypervolemia; congestive cardiac failure, HTN, oesophageal varices, hemorrhagic diathesis, severe anaemia, renal or post-renal anuria. Patients on controlled Na diet. Assure adequate hydration of patients. Carefully monitor patients against circulatory overload & hyperhydration; haemodynamic parameters; electrolyte status. Ensure adequate substitution of other blood constituents (coagulation factors, electrolytes, platelets & erythrocytes). Pregnancy & lactation. Childn & adolescents 0-18 yr.